These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27447841)

  • 21. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort.
    Saracino A; Lorenzini P; Lo Caputo S; Girardi E; Castelli F; Bonfanti P; Rusconi S; Caramello P; Abrescia N; Mussini C; Monno L; d'Arminio Monforte A;
    Clin Microbiol Infect; 2016 Mar; 22(3):288.e1-8. PubMed ID: 26551839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study.
    Cesar C; Jenkins CA; Shepherd BE; Padgett D; Mejía F; Ribeiro SR; Cortes CP; Pape JW; Madero JS; Fink V; Sued O; McGowan C; Cahn P;
    Lancet HIV; 2015 Nov; 2(11):e492-500. PubMed ID: 26520929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of patients infected with HIV through use of injected drugs compared to patients infected through sexual transmission: late presentation, delayed anti-retroviral treatment and higher mortality.
    Suárez-García I; Sobrino-Vegas P; Dalmau D; Rubio R; Iribarren JA; Blanco JR; Gutierrez F; Montero Alonso M; Bernal E; Vinuesa García D; Del Amo J;
    Addiction; 2016 Jul; 111(7):1235-45. PubMed ID: 26890155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Value of HIV-1 RNA on CD4 Trajectories and Disease Progression Among Antiretroviral-Naive HIV-Infected Adults in Botswana: A Joint Modeling Analysis.
    Farahani M; Novitsky V; Wang R; Bussmann H; Moyo S; Musonda RM; Moeti T; Makhema JM; Essex M; Marlink R
    AIDS Res Hum Retroviruses; 2016 Jun; 32(6):573-8. PubMed ID: 26830351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial.
    ENCORE1 Study Group
    Lancet; 2014 Apr; 383(9927):1474-1482. PubMed ID: 24522178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL.
    Madeddu G; Rusconi S; Cozzi-Lepri A; Di Giambenedetto S; Bonora S; Carbone A; De Luca A; Gianotti N; Di Biagio A; Antinori A;
    Infection; 2017 Aug; 45(4):521-528. PubMed ID: 28477212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simplification therapy with once-daily didanosine, tenofovir and efavirenz in HIV-1-infected adults with viral suppression receiving a more complex antiretroviral regimen: final results of the EFADITE trial.
    Barrios A; Negredo E; Domingo P; Estrada V; Labarga P; Asensi V; Morales D; Santos J; Clotet B; Soriano V;
    Antivir Ther; 2005; 10(7):825-32. PubMed ID: 16312178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study.
    Cook RL; Zhou Z; Kelso-Chichetto NE; Janelle J; Morano JP; Somboonwit C; Carter W; Ibanez GE; Ennis N; Cook CL; Cohen RA; Brumback B; Bryant K
    Addict Sci Clin Pract; 2017 Sep; 12(1):22. PubMed ID: 28950912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A two-sex model for the influence of heavy alcohol consumption on the spread of HIV/AIDS.
    Thomas G; Lungu EM
    Math Biosci Eng; 2010 Oct; 7(4):871-904. PubMed ID: 21077713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between alcohol consumption trajectories and clinical profiles among women and men living with HIV.
    Kelso-Chichetto NE; Plankey M; Abraham AG; Ennis N; Chen X; Bolan R; Cook RL
    Am J Drug Alcohol Abuse; 2018; 44(1):85-94. PubMed ID: 28621562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment.
    Crane HM; McCaul ME; Chander G; Hutton H; Nance RM; Delaney JAC; Merrill JO; Lau B; Mayer KH; Mugavero MJ; Mimiaga M; Willig JH; Burkholder GA; Drozd DR; Fredericksen RJ; Cropsey K; Moore RD; Simoni JM; Christopher Mathews W; Eron JJ; Napravnik S; Christopoulos K; Geng E; Saag MS; Kitahata MM
    AIDS Behav; 2017 Jul; 21(7):1914-1925. PubMed ID: 28285434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naïve HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands (ATHENA) cohort.
    Rokx C; Gras L; van de Vijver D; Verbon A; Rijnders B;
    HIV Med; 2016 Sep; 17(8):571-80. PubMed ID: 26842457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.
    Manosuthi W; Sungkanuparph S; Tantanathip P; Lueangniyomkul A; Mankatitham W; Prasithsirskul W; Burapatarawong S; Thongyen S; Likanonsakul S; Thawornwa U; Prommool V; Ruxrungtham K;
    Clin Infect Dis; 2009 Jun; 48(12):1752-9. PubMed ID: 19438397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alcohol Consumption and Risky Sexual Behavior Among Persons Attending Alcohol Consumption Venues in Gaborone, Botswana.
    Lama TP; Kumoji E'; Ketlogetswe D; Anderson M; Brahmbhatt H
    Prev Sci; 2016 Feb; 17(2):227-36. PubMed ID: 26450847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of antiretroviral treatment in HIV-infected adults: a dynamic and observational cohort study in Shenzhen, China, 2003-2014.
    Huang P; Tan J; Ma W; Zheng H; Lu Y; Wang N; Peng Z; Yu R
    BMJ Open; 2015 May; 5(5):e007508. PubMed ID: 26002691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant reductions in alcohol use after hepatitis C treatment: results from the ANRS CO13-HEPAVIH cohort.
    Knight R; Roux P; Vilotitch A; Marcellin F; Rosenthal E; Esterle L; Boué F; Rey D; Piroth L; Dominguez S; Sogni P; Salmon-Ceron D; Spire B; Carrieri MP;
    Addiction; 2017 Sep; 112(9):1669-1679. PubMed ID: 28430385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Enane LA; Lowenthal ED; Arscott-Mills T; Matlhare M; Smallcomb LS; Kgwaadira B; Coffin SE; Steenhoff AP
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1320-1325. PubMed ID: 27725042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of universal access to antiretroviral therapy on HIV stigma in Botswana.
    Wolfe WR; Weiser SD; Leiter K; Steward WT; Percy-de Korte F; Phaladze N; Iacopino V; Heisler M
    Am J Public Health; 2008 Oct; 98(10):1865-71. PubMed ID: 18703447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Cannabis, Stimulant, and Alcohol use with Mortality Prognosis Among HIV-Infected Men.
    Adams JW; Bryant KJ; Edelman EJ; Fiellin DA; Gaither JR; Gordon AJ; Gordon KS; Kraemer KL; Mimiaga MJ; Operario D; Tate JP; van den Berg JJ; Justice AC; Marshall BDL
    AIDS Behav; 2018 Apr; 22(4):1341-1351. PubMed ID: 28887669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in retrospectively recalled alcohol use pre, during and post alcohol sales prohibition during COVID pandemic in Botswana.
    Maphisa JM; Mosarwane K
    Int J Drug Policy; 2022 Apr; 102():103590. PubMed ID: 35091312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.